CASE REPORT |
|
Year : 2022 | Volume
: 14
| Issue : 6 | Page : 216-217 |
|
Psoriasiform drug eruption to finasteride: Uncommon side effect of a commonly used drug
Aishwarya Muddebihal1, Ananta Khurana1, Anita Kulhari1, Arvind Ahuja2
1 Department of Dermatology, Venereology and Leprosy, Atal Bihari Vajpayee Institute of Medical Sciences and Dr. RML Hospital, New Delhi, India 2 Department of Pathology, Atal Bihari Vajpayee Institute of Medical Sciences and Dr. RML Hospital, New Delhi, India
Correspondence Address:
Aishwarya Muddebihal Department of Dermatology, Venerology and Leprosy, Atal Bihari Vajpayee Institute of Medical Sciences and Dr. RML Hospital, New Delhi - 110 001 India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/ijt.ijt_42_21
|
|
Finasteride, a 5-α reductase inhibitor, is generally well tolerated on long-term use and cutaneous adverse events have rarely been observed with the drug. We present the case of a 25-year-old male who developed an extensive psoriasiform eruption within a week of starting finasteride 1 mg for androgenetic alopecia.
|
|
|
|
[FULL TEXT] [PDF]* |
|
 |
|